Distribution of Choroidal Thinning in High Myopia, Diabetes Mellitus, and Aging: A Swept-Source OCT Study by Bartol-Puyal, Francisco de Asís et al.
Research Article
Distribution of Choroidal Thinning in High Myopia, Diabetes
Mellitus, and Aging: A Swept-Source OCT Study
Francisco de Ası´s Bartol-Puyal ,1,2 Carlos Isanta,1,2 O´scar Ruiz-Moreno,1,2,3
Beatriz Abadia ,2 Pilar Calvo ,1,2 and Luis Pablo1,2,3
1Ophthalmology Department, Miguel Servet University Hospital, Zaragoza, Spain
2Ophthalmology Innovative and Research Group (GIMSO), Arago´n Institute for Health Research (IIS Arago´n), Zaragoza, Spain
3University of Zaragoza, Zaragoza, Spain
Correspondence should be addressed to Francisco de As´ıs Bartol-Puyal; franbarpuy@hotmail.com
Received 26 February 2019; Accepted 29 July 2019; Published 15 August 2019
Guest Editor: Hema Radhakrishnan
Copyright © 2019 Francisco de As´ıs Bartol-Puyal et al. -is is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the original work is
properly cited.
Purpose. To compare the macular choroidal thinning between young healthy, aged healthy, young high myopic, and aged type 2
diabetic (T2D) patients using the Early Treatment Diabetic Retinopathy Study (ETDRS) grid and three-dimensional (3D) maps.
Methods. A prospective study including 102 eyes of 51 healthy young subjects, 60 eyes of 30 healthy aged subjects, 24 eyes of 12
high myopic patients, and 110 eyes of 55 T2D patients. Choroidal thickness (CT) was examined with swept-source optical
coherence tomography Triton DRI (Topcon Corporation, Tokyo, Japan). -e choroid was automatically segmented using the
software algorithm, andmean CTvalues of a 6× 6mmmacular cube were exported. 3Dmaps were created to represent CT, and its
values were compared using the ETDRS grid. Results. Mean age was 27.31± 3.95, 66.41± 7.54, 27.69± 3.89, and 66.48± 7.59 years
in young healthy, aged healthy, young high myopic, and T2D patients, respectively. CTwas not shown to be uniform, as superior
and central zones were thicker. All ETDRS sectors were always thicker (p< 0.05) in young healthy individuals than in the others. It
was found that the choroidal sector which got thinner was inferior in case of age (103.28 μm decrease), inferior-nasal in high
myopia (86.19 μm decrease), and temporal in T2D (55.57 μm decrease). In addition, the choroid got thinner in those regions
where it was thicker in healthy subjects. Conclusions. 3Dmaps allow a further comprehension of choroidal changes.-e choroidal
pattern in young healthy individuals resembles a mountain range; with age, a mountain peak; in high myopia, an inverted gorge;
and in aged T2D, gathered hills. Not all choroidal regions are affected in a similar way, as it depends on the pathology.-e thicker
the zone is in healthy subjects, the thinner it becomes with any pathology.
1. Introduction
With the advent of optical coherence tomography (OCT)
technology, the choroid has been precisely visualized for the
past few years. It has been proved to play an important role
in different retinal disorders such as myopia, central serous
chorioretinopathy, and age-related macular degeneration.
Quantitative assessment of the choroid has allowed new
research findings to differentiate normal from pathological
processes within the choroid. It is known that choroidal
thickness (CT) varies with age [1–3], axial length (AL) [4–7],
day time [8–10], and race [11]. A choroidal thinning has
been found in pathologies such as myopia [12] and diabetes
mellitus [13–15], and a relevant thickening has been found in
the pachychoroid spectrum, which includes the polypoidal
choroidal vasculopathy [16].
Swept-source OCT (SS-OCT) is the last generation of
OCT, and it uses a laser source of a longer wavelength
(1050 nm) which penetrates deeper in the retinal and cho-
roidal tissues than conventional laser sources used in pre-
vious spectral-domain OCT devices [17].
SS-OCT provides retinal and choroidal macular thick-
ness geographically displayed as a false-color topographic
map, and it is numerically reported as averages in each of the
nine regions defined by the Early Treatment Diabetic Ret-
inopathy Study (ETDRS) [11]. -e ETDRS grid includes a
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central disc of 500 μm of diameter (foveal region) and an
inner and an outer ring; each one was divided into four
quadrants, with a diameter of 3000 μm and 6000 μm, re-
spectively. -is grid is used for quantitative evaluations of
either retinal or choroidal thickness.
-is study aimed to evaluate the distribution of cho-
roidal thinning in high myopia, diabetes mellitus, and aging
using the classic ETDRS grid from SS-OCT and a new
different mapping.
2. Methods
2.1. Sample Selection. Over a 2-year duration (from No-
vember 2015 to November 2017), we performed a cross-
sectional SS-OCT study on four different groups of patients:
young healthy subjects (group 1), senior healthy subjects
(group 2), young high-myopic patients (group 3), and pa-
tients with type 2 diabetes mellitus (T2D) (group 4). All
patients underwent a complete ophthalmic evaluation at the
Miguel Servet University Hospital in Zaragoza, Spain. -e
study protocol adhered to the tenets of the Declaration of
Helsinki and was approved by the Institutional Review
Board (Clinical Research Ethics Committee of Arago´n
(CEICA)).
Exclusion criteria were a race different from Caucasian,
any ocular pathology or previous treatment, amblyopia,
endocrine or neurological diseases, cancer history, corti-
costeroids, and immunosuppressive drugs.
Group 1 included young healthy volunteers between 18
and 35 years old and with an AL≤ 25mm. Group 2 included
senior healthy volunteers between 55 and 75 years old and
with an AL≤ 25mm. Group 3 included young healthy pa-
tients between 18 and 35 years old but with an AL≥ 25mm.
Group 4 included T2D patients between 55 and 75 years old,
with mild or moderate diabetic retinopathy (DR), without
macular oedema and without any previous ophthalmolog-
ical treatment. Healthy individuals’ medical records were
examined in order to verify that all of them had no systemic
illnesses. T2D patients were diagnosed after the criteria of
the American Diabetes Association, and all of them were
negative for anti-glutamic acid decarboxylase antibodies.
2.2. Study Protocol. Patients underwent a deep ophthal-
mological examination which included best-corrected visual
acuity (BCVA), refraction, slit-lamp examination, in-
traocular pressure (IOP) with Goldmann applanation to-
nometry, optical biometry (IOLMaster 500, Carl Zeiss
Meditec, Jena, Germany), indirect funduscopy, and SS-OCT
Triton Deep Range Image (Topcon Corporation, Tokyo,
Japan).
SS-OCT scans were acquired through dilated pupils at
the same day time and by an experienced technician. A
macular 6 × 6mm three-dimensional (3D) cube centered
on the fovea was analysed three times, but only the best
examination was selected for the analysis. Scans with low
quality (<40/100), motion artifacts, or decentration were
discarded. -e choroidal segmentation was automatically
performed using the on-board device software. In case of
segmentation errors, manual corrections of individual A-
scans were performed to fit the choroidal boundaries
(from the outer edge of the hyper-reflective retinal pig-
ment epithelial line to the inner edge of the sclera).
In every OCT image, the ETDRS grid was centered on
the fovea, and measurements of the nine choroidal subfields
were obtained and compared between groups.
Besides the classic ETDRS grid, a fovea-centered map
composed of 30 × 30 cubes was generated with automatic
measurements of CT. -is map comprised 900
200 × 200 μm cubes. Mean CT in every cube was exported
and analysed. -e left eyes were converted into the right
eye format.
As a reference, young healthy subjects’ choroid (group 1)
was divided into different zones according to the mean CTin
every macular cube (Figure 1). Zone 1 included those
macular points with a CT between 215 and 239 μm, zone 2
between 240 and 264 μm, zone 3 between 265 and 290 μm,
zone 4 between 290 and 314 μm, and zone 5 between 315 and
340 μm. -e 5 zones were then divided into nasal and
temporal, obtaining a total of 10 measurements. -e mean
CT of equivalent zones was calculated and compared be-
tween groups.
-e two-dimensional (2D)maps of the four study groups
were created with Microsoft Word (Microsoft Corporation),
and Microsoft Excel (Microsoft Corporation) was used for
the three-dimensional (3D) maps.
2.3. Statistical Analysis. Statistical analyses were performed
using IBM SPSS (version 23.0; IBM Corporation, Somers,
NY, USA) statistical software. All variables followed a
normal distribution as verified by the Kolmogorov–Smirnov
test. A two-tailed Student’s t-test was used to compare CT
between groups using both the classic ETDRS grid (9 re-
gions) and the new choroidal distribution (10 regions). In
case of comparisons involving group 3, a Mann–Whitney U
test was performed due to the insufficient number of cases.
For all analyses, p< 0.05 was considered as statistically
significant.
2.4. Demographics. We enrolled 102 eyes of 51 healthy
young subjects (group 1), 60 eyes of 30 healthy aged
subjects (group 2), 24 eyes of 12 high-myopic patients
(group 3), and 110 eyes of 55 aged patients with diabetes
mellitus type 2 (group 4) with mild or moderate diabetic
retinopathy and without macular oedema. Mean age
outcomes in the four study groups are displayed in Table 1.
-ere were no differences between mean ages of groups 1
(young healthy) and 3 (young myopic) (p � 0.79) and
between groups 2 (aged healthy) and 4 (aged diabetic)
(p � 0.09). -ere were no differences between the best-
corrected visual acuity between groups 1 and 3 (p � 0.97),
but there were between groups 2 and 4 (p< 0.001). -ere
were no differences regarding intraocular pressure be-
tween groups 1 and 3 (p � 0.83), between 2 and 4
(p � 0.14), and between 1 and 2 (p � 0.08). -ere were
differences in AL between groups 1 and 3 (p< 0.001), but
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there were not between groups 1 and 2 (p � 0.33) and
between groups 2 and 4 (p � 0.17).
3. Results
3.1. Choroidal Measurements. Average CT values are dis-
played in Table 2. When evaluating choroid with the ETDRS
grid, the thickest choroid was found in the inner temporal
(317.65± 72.30 μm), inner superior (240.35± 62.92 μm),
outer superior (247.78± 61.79 μm), and inner superior
(191.68± 76.31 μm) sectors in groups 1, 2, 3, and 4, re-
spectively. When evaluating choroid with the new choroidal
division, the thickest choroid was found in zone 5 nasal
(320.93± 67.90 μm), zone 5 temporal (236.51± 60.98 μm),
zone 5 temporal (250.50± 56.96 μm), and zone 5 temporal
(189.76± 66.24 μm) in groups 1, 2, 3, and 4, respectively.
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Figure 1: Choroidal zones in group 1 (young healthy individuals).
Table 1: Demographic and general ophthalmological factors.
Group 1 (young healthy) Group 2 (senior healthy) Group 3 (young high myopic) Group 4 (senior T2 DM)
Age (years) 27.31± 3.95 66.41± 7.54 27.69± 3.89 66.48± 7.59
BCVA (decimal scale) 0.99± 0.07 0.89± 0.13 0.99± 0.03 0.75± 0.23
IOP (mmHg) 16.07± 2.38 16.09± 2.56 16.81± 3.01 16.76± 2.96
AL (mm) 23.68± 0.73 23.97± 1.39 25.83± 0.70 23.21± 0.92
Number of eyes (patients) 102 (51) 60 (30) 24 (12) 110 (55)
BCVA� best-corrected visual acuity; IOP� intraocular pressure; AL� axial length.
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Table 3 shows the CT comparison between groups using
ETDRS and the new division. CT was always significantly
thicker (p< 0.01) in group 1 (young healthy) than in groups
2 and 3. Group 2 (aged healthy) always showed to have a
thicker choroid (p< 0.02) than group 4 (aged diabetic). p
values are shown in Table 3 too.
For a better understanding, Figure 2 shows a visual
representation of the thinning using the ETDRS grid. In this
figure, the darker, the more the choroid gets thinned.
3.2. Choroidal Maps Using the New Choroidal Division.
Figure 3 shows a colored 2D representation of CT in the four
study groups. Black lines were drawn following the results in
group 1 (young healthy) to allow an easier comparison. Figure 4
shows a 3D representation of CT in the four study groups. It
does not represent the real choroidal shape, as it is just a
mathematical representation of its thickness on a flat surface.
Nevertheless, the combination of these 2D and 3Dmaps allows
better and easier understanding and visual comparison.
Table 2: Choroidal thickness using the ETDRS grid.
ETDRS sector
Young healthy
(group 1)
Aged healthy
(group 2)
Young myopic
(group 3) Aged diabetic (group 4)
Mean (μm) SD Mean (μm) SD Mean (μm) SD Mean (μm) SD
Center 315.73 37.12 237.75 68.57 239.00 60.30 186.24 69.89
Inner temporal 317.65 72.30 231.30 62.62 246.10 60.85 175.73 67.17
Inner superior 309.11 68.58 240.35 62.92 240.79 60.04 191.68 76.31
Inner nasal 285.95 70.71 218.63 70.19 201.57 59.60 173.82 75.09
Inner inferior 317.22 73.91 219.31 65.44 231.03 62.13 174.61 68.70
Outer temporal 300.63 70.89 212.80 56.27 240.70 58.47 160.24 59.38
Outer superior 312.02 67.68 235.46 63.92 247.78 61.79 185.55 68.34
Outer nasal 224.53 68.67 169.29 70.70 150.73 51.19 137.06 71.78
Outer inferior 302.42 74.12 199.13 62.81 228.59 56.20 160.28 63.21
Sector of the new division
Zone 1 nasal 234.71 93.06 169.33 73.10 175.31 77.57 137.57 71.43
Zone 1 temporal 232.19 80.77 170.32 66.48 184.43 79.29 137.93 62.21
Zone 2 nasal 255.33 87.33 178.05 66.33 189.50 69.62 142.66 64.57
Zone 2 temporal 253.88 75.41 181.00 63.64 196.54 70.98 141.28 59.14
Zone 3 nasal 279.29 70.04 196.30 62.86 206.77 64.19 154.60 64.39
Zone 3 temporal 277.77 71.42 198.19 62.05 214.47 62.26 155.73 60.61
Zone 4 nasal 304.85 71.60 217.00 59.71 229.41 57.96 172.11 64.49
Zone 4 temporal 303.68 66.63 218.29 60.37 235.26 56.23 174.23 62.90
Zone 5 nasal 320.93 67.90 234.10 59.93 246.21 58.39 185.62 66.61
Zone 5 temporal 320.92 67.37 236.51 60.98 250.50 56.96 189.76 66.24
Table 3: Choroidal thickness comparison between groups.
ETDRS region
Groups 1-2 Groups 1–3 Groups 2–4
CT reduction (μm) p CT reduction (μm) p CT reduction (μm) p
Center 77.98 <0.001 76.73 <0.001 51.52 <0.001
Inner temporal 86.36 <0.001 71.54 <0.001 55.57 <0.001
Inner superior 68.77 <0.001 68.32 <0.001 48.66 <0.001
Inner nasal 67.30 <0.001 84.38 <0.001 44.81 <0.001
Inner inferior 97.89 <0.001 86.19 <0.001 44.70 <0.001
Outer temporal 87.83 <0.001 52.93 <0.001 52.56 <0.001
Outer superior 76.58 <0.001 64.25 <0.001 49.91 <0.001
Outer nasal 55.25 <0.001 73.80 <0.001 32.22 <0.001
Outer inferior 103.28 <0.001 73.83 <0.001 38.85 <0.001
Sector of the new division
Zone 1 nasal 65.38 <0.001 59.40 <0.001 31.76 <0.001
Zone 1 temporal 61.88 <0.001 47.76 <0.001 32.38 <0.001
Zone 2 nasal 77.27 <0.001 65.83 <0.001 35.39 <0.001
Zone 2 temporal 72.89 <0.001 57.34 <0.001 39.72 <0.001
Zone 3 nasal 82.99 <0.001 72.52 <0.001 41.69 <0.001
Zone 3 temporal 79.57 <0.001 63.29 <0.001 42.47 <0.001
Zone 4 nasal 87.85 <0.001 75.44 <0.001 44.89 <0.001
Zone 4 temporal 85.39 <0.001 68.42 <0.001 44.05 <0.001
Zone 5 nasal 86.83 <0.001 74.71 <0.001 48.48 <0.001
Zone 5 temporal 84.40 <0.001 70.42 <0.001 46.76 <0.001
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-e thickest choroidal region was always superocentral
to the fovea, showing a kind of ellipsoid shape. In young
healthy individuals (group 1), it resembled a mountain range
with its peaks and the valleys at both sides. In case of the
other groups, the choroid tended to be flatter and the pattern
was not always preserved. -e aged healthy group (number
2) showed a higher reduction of CT in the inferior side,
resulting in a choroidal pattern which resembled a single
mountain peak. Something different happened with the
young myopic patients (group 3), whose CT pattern stayed
similar to the young healthy patients (group 1) but with a
remarkable choroidal thinning on nasal and temporal sides.
It resembled an inverted gorge. Finally, aged diabetic pa-
tients (group 4) showed to have the flattest choroid and its
pattern was close to aged healthy patients’ one (group 2), but
instead of mountain peak, it was more similar to gathered
hills.
4. Discussion
A thin choroid has been associated with ocular and systemic
disorders, and sometimes can be useful in the differential
diagnostic of some pathologies, such as between age-related
macular degeneration and polypoidal choroidal vasculopathy
Groups 1 and 2—ETDRS grid Groups 1 and 2—new choroidal division 
Groups 1 and 3—ETDRS grid Groups 1 and 3—new choroidal division 
Groups 2 and 4—ETDRS grid Groups 2 and 4—new choroidal division 
Figure 2: Mean choroidal thinning.
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[16]. One of the SS-OCTused so far for a deep comprehensive
choroidal study has been Triton DRI. Its repeatability and
reliability have been proved in healthy patients [18, 19] and in
choroid-thickness thinning pathologies [20]. It gives similar
measurements to the Zeiss Cirrus HD-OCT [21] (Carl Zeiss)
although results should not be interchangeable [18]. It has
been stated that automatic measurements reduce variability
[22] although there is still little possibility of scan artifacts [23].
-emost commonly used pattern is the ETDRS grid, as it
is in retina, too. Nevertheless, the composition and functions
of choroid has nothing to do with the ones of retina and its
thickness does not follow the same pattern [5, 6, 12]. Al-
though retinal thickness is not the same among ETDRS
sectors, it does not differ too much [24], and that is why the
ETDRS grid is an adequate useful pattern, whereas it might
not be for choroid. However, no choroidal division has been
proposed so far.
Choroid has usually been analysed with the ETDRS grid
or with horizontal lines. At a first glance, the overall
thickness map does not differ too much from the ones al-
ready published and mean CT values are similar, too. Some
authors have described higher values of CT in superior parts
[5, 6, 25] and the lowest in the outer macula area
[5, 6, 26, 27], as well as we have. -e fact of having analysed
together right and left eyes should not have biased our study,
as already stated by Chen et al. [28].
Shin et al. tried to make a choroidal map using radial
OCT scans of the choroid and with the ETDRS grid, but
they used a SD-OCT [26], and so the exact thickness
values may differ. In our study, we found that the thickest
choroid was always located in the superocentral area and
the thinnest in temporal and nasal zones. With choroidal-
thinning pathologies, the resulting CT map tends to be
rather flat. However, the choroidal pattern differs
depending on the pathology. Young healthy individuals
show a mountain range pattern; aged healthy subjects, a
mountain peak pattern; young high myopic, an inverted
gorge pattern; and aged diabetic patients a gathered hills
pattern, as displayed in Figures 3 and 4. -is is why a 3D
representation of CT has an importance, as it gives more
information than ETDRS values alone.
-e thickness range of 25 μm for every color range in our
maps is acceptable, as it is higher than the possible internal
variation of the OCT but not so high that it remained
unaltered with affecting pathologies. Rahman et al. stated
that a manually measured change greater than 23 μm in the
subfoveal field may represent choroidal change when using
SD-OCT with enhanced depth imaging (EDI) and manual
measuring [22].
Although all the choroid and its sectors get significantly
thinner with age, not all the sectors become equally af-
fected. Bafiq et al. studied CT variation with age using
manual measurements, and they found that the central
choroidal thickness increased with age, the most thinned
sector was the nasal outer one, and the second most
thinned was the inferior ones, what differs to some extent
to our results [11]. -e outer inferior ETDRS grid sector is
the most thinned, and the outer nasal one is the less
Group 1—young healthy subjects Group 2—senior healthy subjects
Group 3—young high-myopic patients Group 4—senior type 2 diabetic patients
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Figure 3: Two-dimensional representation of choroidal thickness.
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thinned. As the latter has already been described as the
thinnest choroidal zone even in healthy subjects, it is easy
to understand that it is more difficult to achieve an even
higher thinning.
On the contrary, high-myopic patients’ choroid does not
experience the same kind of thinning as with age.-eir most
thinned ETDRS sectors are the inferior and the nasal. Zhang
et al. already found that the temporal choroid becomes less
thinned than nasal, but they did not examine the superior or
inferior choroid [12].
Finally, aged patients with mild and moderate DR suffer
from a choroidal thinning which is softer in the outer nasal
ETDRS sector. -eir outer inferior ETDRS sector is affected
from little thinning as well, but we should consider that this
sector was already thinned because of age and then an even
higher choroidal thinning would be rather difficult to
achieve.
-us, it is noticeable that, under these pathologies, there
is a considerable flattening, and in those zones where CTwas
higher, choroidal thinning is also greater.
-e strengths of this study include study-na¨ıve patients
and SS-OCT automatic measurements performed at the
same day time. Furthermore, thickness maps seem easier to
evaluate the choroid than manual measurements or ETDRS
numerical values.
-e main limitations of this study are a low number of
young high-myopic patients and the small quantity of
choroidal-thinning pathologies evaluated. It would be of
interest how the whole macular choroid changes in other
situations.
In conclusion, choroidal-thinning pathologies affect
choroidal regions in a different way.-is fact gains relevance
especially in choroidal measurements because not all regions
are interchangeable and CT should be measured in the
proper place depending on the particular pathology.
-erefore, lineal OCT examinations are inadequate for
choroidal evaluation as superior and inferior macular re-
gions remain unanalyzed. Second, choroidal thinning fol-
lows the following rule: the thicker the zone is in healthy
subjects, the thinner it becomes when affected by any
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Figure 4: 3D maps of choroidal thickness.
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pathology. -ird, 3D representations of CT provide us with
visual information which helps us to make an easier and
faster general valuation. In general lines, the choroid in
young healthy individuals follows a mountain range pattern;
in aged healthy subjects, it follows a mountain peak pattern;
in young high-myopic patients, it follows an inverted gorge
pattern; and in aged diabetic patients, it follows a gathered
hills pattern. All these pathologies tend to make a flat
uniform choroid.
Data Availability
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